biotech deals

Ferrer nabs European rights for ALS asset in €500M pact

Ferrer is paying 80 million euros upfront to jointly develop neurodegenerative disease candidate pridopidine in Europe with Dutch biotech Prilenia Tx.

Darren Incorvaia Apr 28, 2025 2:40pm

GPS navigation to pins and multiple markers on route

Genentech builds autoimmune Repertoire with $765M deal

Apr 23, 2025 7:00am

Merck links up with Cyprumed in $493M oral peptide deal

Apr 15, 2025 1:11pm

Vibrant colored closed wooden doors in a row on blue sky and sea background

Chimerix had 8 suitors: Why Jazz won out

Mar 21, 2025 5:17pm

Space shuttle takes off on background of blue sky

Manufacturer Emergent invests in next-gen vax biotech

Mar 12, 2025 10:22am

Novartis hands over $55M to license preclinical hives prospect

Mar 3, 2025 5:05pm